Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Bayer withdraws follicular lymphoma drug after further trial fails
FRANKFURT (Reuters) - Bayer on Monday said it would voluntarily withdraw the follicular lymphoma drug Aliqopa, also known as copanlisib, from the U.S. market after a trial designed to confirm its bene...
Nov 13, 2023
Aclaris shares plummet on terminating development of rheumatoid arthritis drug
(Reuters) -Aclaris Therapeutics on Monday said it would stop development of its rheumatoid arthritis treatment after it failed in a mid-stage trial, sending its shares plunging 84% before the bell. Th...
Nov 13, 2023
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular ...
Nov 13, 2023
Critically ill British girl dies after life support removed – family
LONDON/ROME (Reuters) -Indi Gregory, a critically ill eight-month-old baby girl from Britain who was taken off life support over the weekend following a legal battle, has died overnight, her family sa...
Nov 13, 2023
EU regulator backs GSK’s bone marrow cancer therapy
(Reuters) - British drugmaker GSK on Monday said the human medicines committee of the European Medicines Agency had recommended approving its oral therapy to treat anaemia in patients with a type of b...
Nov 13, 2023
New satellite will detect and share CO2 data from individual facilities
(Reuters) - Canadian emissions monitoring company GHGSat on Saturday launched a satellite aimed at detecting carbon dioxide emissions from individual facilities like coal plants and steel mills from s...
Nov 11, 2023
Novo Nordisk says Wegovy heart benefits due to more than weight loss
By Patrick Wingrove PHILADELPHIA (Reuters) - Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone, accordin...
Nov 11, 2023
AstraZeneca prioritizes US for RSV drug amid surge in cases
By Patrick Wingrove and Maggie Fick NEW YORK (Reuters) - AstraZeneca on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, wh...
Nov 10, 2023
UK court rejects appeal over where critically ill baby’s treatment ends
By Kylie MacLellan LONDON (Reuters) -The parents of a critically ill British baby girl on Friday lost their legal bid to have her life support removed at home rather than in a hospital or hospice. Eig...
Nov 10, 2023
India’s Glenmark Pharma posts Q2 loss on exceptional legal costs
HYDERABAD (Reuters) - India's generic drugmaker Glenmark Pharmaceuticals reported a loss in the second quarter, hurt by exceptional costs related to a legal settlement and higher expenses. The company...
Nov 10, 2023
